Court Rejects Amgen’s Ask to Halt Colorado Drug Payment Caps (1)

Colorado’s prescription drug review board can move move forward with limiting what health plans pay for selected drugs after a federal judge on Friday rejected Amgen Inc.‘s request to enjoin the panel from capping payments.

Amgen lacks standing because it is not subject to direct regulation under the law allowing the Colorado Prescription Drug Affordability Board to set limits for some of the costliest drugs in the state, Judge Nina Y. Wang for the US District Court of the District of Colorado said in her opinion dismissing the case.

The law states that an upper payment limit will apply ...